Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Harshad P. Patil
Observed name:
Harshad P Patil
Institution:
Bharati Vidyapeeth (Deemed to be University)
Observed institutions:
University Medical Center Groningen,
University of Groningen,
Bharati Vidyapeeth (Deemed to be University),
UCLouvain
ORCID:
0000-0002-2345-9266
Observed ORCID:
0000-0002-2345-9266
OpenAlex ID:
A5035952908
Works
29
Awards
1
PEGylation of paclitaxel largely improves its safety and anti-tumor efficacy following pulmonary delivery in a mouse model of lung carcinoma
2016
·
Tian Luo
, Cristina Loira-Pastoriza
, et al.
·
Journal of Controlled Release
·
73
PDF
Evaluation of monophosphoryl lipid A as adjuvant for pulmonary delivered influenza vaccine
2013
·
Harshad P. Patil
, Senthil Murugappan
, et al.
·
Journal of Controlled Release
·
55
Advax augments B and T cell responses upon influenza vaccination via the respiratory tract and enables complete protection of mice against lethal influenza virus challenge
2018
·
Jasmine Tomar
, Harshad P. Patil
, et al.
·
Journal of Controlled Release
·
53
PDF
Fate of PEGylated antibody fragments following delivery to the lungs: Influence of delivery site, PEG size and lung inflammation
2017
·
Harshad P. Patil
, Danielle Freches
, et al.
·
Journal of Controlled Release
·
49
Physical and immunogenic stability of spray freeze-dried influenza vaccine powder for pulmonary delivery: Comparison of inulin, dextran, or a mixture of dextran and trehalose as protectants
2013
·
Senthil Murugappan
, Harshad P. Patil
, et al.
·
European Journal of Pharmaceutics and Biopharmaceutics
·
40
Antibody (IgA, IgG, and IgG Subtype) Responses to SARS-CoV-2 in Severe and Nonsevere COVID-19 Patients
2021
·
Harshad P. Patil
, Prajakta S. Rane
, et al.
·
Viral Immunology
·
37
Enhancement of the Immunogenicity and Protective Efficacy of a Mucosal Influenza Subunit Vaccine by the Saponin Adjuvant GPI-0100
2012
·
Heng Liu
, Harshad P. Patil
, et al.
·
PLoS ONE
·
33
PDF
PEGylation prolongs the pulmonary retention of an anti-IL-17A Fab’ antibody fragment after pulmonary delivery in three different species
2017
·
Danielle Freches
, Harshad P. Patil
, et al.
·
International Journal of Pharmaceutics
·
27
Pulmonary immunization: deposition site is of minor relevance for influenza vaccination but deep lung deposition is crucial for hepatitis B vaccination
2019
·
Jasmine Tomar
, Wouter F. Tonnis
, et al.
·
Acta Pharmaceutica Sinica B
·
25
PDF
Production and characterization of a PEGylated derivative of recombinant human deoxyribonuclease I for cystic fibrosis therapy
2017
·
Marie-Julie Guichard
, Harshad P. Patil
, et al.
·
International Journal of Pharmaceutics
·
25
Comparison of adjuvants for a spray freeze-dried whole inactivated virus influenza vaccine for pulmonary administration
2015
·
Harshad P. Patil
, Senthil Murugappan
, et al.
·
European Journal of Pharmaceutics and Biopharmaceutics
·
20
PDF
Simplifying Influenza Vaccination During Pandemics: Sublingual Priming and Intramuscular Boosting of Immune Responses with Heterologous Whole Inactivated Influenza Vaccine
2014
·
Senthil Murugappan
, Harshad P. Patil
, et al.
·
The AAPS Journal
·
20
Evaluation of Mucosal and Systemic Immune Responses Elicited by GPI-0100- Adjuvanted Influenza Vaccine Delivered by Different Immunization Strategies
2013
·
Heng Liu
, Harshad P. Patil
, et al.
·
PLoS ONE
·
20
PDF
Anti-SARS-CoV-2 IgG antibody response among Indian COVID-19 patients using β-propiolactone-inactivated, whole virus-based indirect ELISA
2020
·
Ruta Kulkarni
, Harshad P. Patil
, et al.
·
Journal of Virological Methods
·
18
PDF
Standardization of ELISA for anti-chikungunya-IgG antibodies and age-stratified prevalence of anti-chikungunya-IgG antibodies in Pune, India
2020
·
Harshad P. Patil
, Prajakta S. Rane
, et al.
·
European Journal of Clinical Microbiology & Infectious Diseases
·
17
PEGylation of Recombinant Human Deoxyribonuclease I Provides a Long‐Acting Version of the Mucolytic for Patients with Cystic Fibrosis
2020
·
Marie‐Julie Guichard
, Tobias Wilms
, et al.
·
Advanced Therapeutics
·
13
Evaluation of monophosphoryl lipid A as an adjuvanted for inactivated chikungunya virus
2022
·
Mrunal Gosavi
, Harshad P. Patil
·
Vaccine
·
11
Age-Dependent Evaluation of Immunoglobulin G Response after Chikungunya Virus Infection
2021
·
Harshad P. Patil
, Mrunal Gosavi
, et al.
·
American Journal of Tropical Medicine and Hygiene
·
11
Preclinical evaluation of topically-administered PEGylated Fab’ lung toxicity
2019
·
Danielle Freches
, Natacha Rocks
, et al.
·
International Journal of Pharmaceutics X
·
7
PDF
Evaluation of dual pathogen recognition receptor agonists as adjuvants for respiratory syncytial virus - virus-like particles for pulmonary delivery
2025
·
Ahmedali S. Mandviwala
, Komal Liman
, et al.
·
Frontiers in Immunology
·
5
Dual pattern recognition receptor ligands CL401, CL413, and CL429 as adjuvants for inactivated chikungunya virus
2023
·
Mrunal Gosavi
, Archana Kulkarni-Munje
, et al.
·
Virology
·
5
Immunoglobulin G Subclass Response After Chikungunya Virus Infection
2022
·
Harshad P. Patil
, Mrunal Gosavi
, et al.
·
Viral Immunology
·
5
Isolation and genetic characterization of SARS-CoV-2 from Indian patients in a single family without H/O travel abroad
2021
·
Shubham Shrivastava
, Harshad P. Patil
, et al.
·
Virus Genes
·
5
PDF
Immunogenicity evaluation of respiratory syncytial virus prefusogenic-F based virus-like-particles consisting of G and M proteins in mice
2025
·
Ahmedali S. Mandviwala
, Archana Kulkarni Munje
, et al.
·
Vaccine
·
4
PDF
Mucosal delivery of a prefusogenic-F, glycoprotein, and matrix proteins-based virus-like particle respiratory syncytial virus vaccine induces protective immunity as evidenced by challenge studies in mice
2024
·
Ahmedali S. Mandviwala
, Anke L.W. Huckriede
, et al.
·
Virology
·
3
Show more works
View as search
Works count:
29
Citation count:
585
H-index:
15
I10-index:
18
Year
Topic
Type